AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 81 min read$OSCR

Blackley Richard Scott sold $908K of OSCR

Blackley Richard Scott (Chief Financial Officer) sold 28,869 shares of Oscar Health, Inc. (OSCR) at $31.45 ($0.91M total) on 2026-09-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Blackley Richard Scott
Published Sep 8, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$OSCR
Neutral
high confidence
Mentioned
$OSCR
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OSCRNeutralLow
01

Why it matters

The sale is modest and unlikely to move the stock; investors may monitor future filings for trends.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

The sale was pre‑arranged under a 10b5‑1 plan, reducing the informational value of the transaction.

Relevance 4/10Novelty 4/10Timing: post‑market filing Sep 8 2026

Background

SEC Form 4 filing discloses insider transactions; required for public companies.

Company-level read

Ticker impact

$OSCRNeutralHigh confidence
Context

CFO Richard Scott sold 28,869 shares for $907,930 via a pre‑arranged 10b5‑1 plan on Sep 3, 2026.

Expected impact

Minimal short‑term impact; price likely unchanged.

Evidence & confidence

The transaction amount (~$0.9 M) is small relative to market cap; CFO remains a large holder (1,046,108 shares).

Market effects

Sector

None; health‑insurance sector unchanged.

Regional

None; US market only.

Global

Low

Counterpoint

What could challenge this read

If the CFO is reducing exposure, it could hint at upcoming negative news not yet public.

Key entities

  • Company
    Oscar Health, Inc.

    US‑listed health‑insurance provider (ticker OSCR).

  • Executive
    Richard Scott Blackley

    Chief Financial Officer of Oscar Health.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

OSCR insider trading history →

Related articles

SEP 16
$OSCRHighAI 8/10

OSCR Looks 33.9% Overvalued on GF Value™ as Oscar Health Revises

Oscar Health (OSCR) revised its 2026 forecasts, raising operating earnings outlook by $100M to $600M-$800M and improving medical loss ratio guidance. Revenue guidance remains $18.7B-$19B. GF Value™ indicates OSCR is 33.9% overvalued at $32.44. The company has a strong GF Score™ of 83/100, with high growth and momentum ratings but middling profitability and valuation. Insiders have sold significantly more shares than they've bought.

gurufocus.com2 min
SEP 16
$OSCRHighAI 8/10

Oscar Health boosts 2026 earnings outlook, affirms revenue

Oscar Health (OSCR) updated its 2026 earnings outlook, lowering its Medical Loss Ratio to 81.0%-82.0% and raising earnings from operations to $600M-$800M. The company reaffirmed revenue guidance of $18.7B-$19.0B and maintained SG&A expense ratio targets. The updates will be discussed at its 2026 Investor Day on September 16, 2026.

tipranks.com2 min
SEP 16
$OSCRHighAI 8/10

Oscar Health raises FY26 earnings guidance by $100 million

Oscar Health (OSCR) raised its 2026 earnings guidance by $100 million, citing improved cost controls. The company expects earnings from operations to range from $600 million to $800 million, with a medical loss ratio of 81.0% to 82.0%. Total revenue guidance remains unchanged at $18.7 billion to $19.0 billion. The stock has gained 85.57% over the past year, reaching a 52-week high of $27.59.

scanx.trade2 min
SEP 5
$CNCMed

CNC, OSCR Stocks Rally After Baird Calls Risk Adjustment Results Favorable

Centene (CNC) and Oscar Health (OSCR) shares rose 6% and 12% respectively after Baird reported favorable risk adjustment results. Baird noted the outcomes support Centene's Q4 commentary and align with Oscar's June investor conference remarks. Molina (MOH) shares also rose 2% despite a minor negative impact. The Centers for Medicare & Medicaid Services released final 2025 risk adjustment data on June 30, affecting insurers' earnings.

stocktwits.com2 min